19-Norandrostenedione

19-Norandrostenedione
19-Norandrostenedione
Systematic (IUPAC) name
(8R,9S,10R,13S,14S)-13-Methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-dione
Clinical data
Pregnancy cat.  ?
Legal status Schedule III (US)
Routes Oral
Identifiers
CAS number 734-32-7 N
ATC code  ?
PubChem CID 92834
DrugBank DB01434
ChemSpider 83803 YesY
Chemical data
Formula C18H24O2 
Mol. mass 272.38 g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

19-Norandrostenedione (4-estrene-3,17-dione, NOR) is a precursor of the anabolic steroid nandrolone. Until 2005 19-Norandrostenedione was available without prescription in United States, where it was marketed as a prohormone, but it is now classified as a Schedule III drug. 19-Norandrostenedione is readily metabolized to nandrolone after oral administration, but its potency to transactivate the androgen receptor dependent reporter gene expression is 10 times lower as compared to dihydrotestosterone (DHT).[1]

In vivo experiments in castrated rats demonstrated that subcutaneous treatment with 19-norandrostenedione resulted only in a stimulation of the weight of the levator ani muscle, while the prostate and seminal vesicle weights remained completely unaffected. In contrast to its metabolite nandrolone, 19-norandrostenedione highly selectively stimulates the growth of the skeletal muscles but has only weak androgenic properties.[1]

In the early 2000s, contamination of androstenedione products with traces of 19-norandrostenedione caused false positives for doping tests for nandrolone because 19-norandrosterone is a metabolite of both nandrolone and 19-norandrostenedione. In a randomized controlled trial trace contamination of androstenedione with 19-norandrostenedione was sufficient for users of androstendione to test positive for nandrolone.[2] This detail became less relevant after androstenedione itself was banned by major sporting bodies.

See also

References

  1. ^ a b Diel P, Friedel A, Geyer H, Kamber M, Laudenbach-Leschowsky U, Schänzer W, Schleipen B, Thevis M, Vollmer G, Zierau O (April 2008). "The prohormone 19-norandrostenedione displays selective androgen receptor modulator (SARM) like properties after subcutaneous administration". Toxicol. Lett. 177 (3): 198–204. doi:10.1016/j.toxlet.2008.01.014. PMID 18325697. http://linkinghub.elsevier.com/retrieve/pii/S0378-4274(08)00023-4. 
  2. ^ Catlin DH, Leder BZ, Ahrens B, Starcevic B, Hatton CK, Green GA, Finkelstein JS (2000). "Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite". JAMA 284 (20): 2618–21. doi:10.1001/jama.284.20.2618. PMID 11086369. http://jama.ama-assn.org/cgi/pmidlookup?view=long&pmid=11086369. 

Wikimedia Foundation. 2010.

Игры ⚽ Поможем решить контрольную работу

Look at other dictionaries:

  • 19-Norandrosterone — IUPAC name (3R,5S,8R,9R,10S,13S,14S) 3 Hydroxy 13 methyl 2,3,4 …   Wikipedia

  • Testosterone — For the film, see Testosterone (film). Testosterone Systematic (IUPAC) name …   Wikipedia

  • Prohormone — A prohormone is a substance that is a precursor to a hormone, usually having minimal hormonal effect by itself. The term has been used in medical science since the middle of the 20th century. Examples of natural, human prohormones include… …   Wikipedia

  • Dihydrotestosterone — Systematic (IUPAC) name (5S,8 …   Wikipedia

  • Nandrolone — Systematic (IUPAC) name 17β Hydroxyestra 4 en 3 one Clinical data Pregnancy cat. X (US) X ( …   Wikipedia

  • Metenolone — Systematic (IUPAC) name (5α,17β) 17 hydroxy 1 methylandrost 1 en 3 one Clinical data AHFS/Drugs.com …   Wikipedia

  • Oxandrolone — Systematic (IUPAC) name 17β hydroxy 17α methyl 2 oxa 5α androstan 3 one Clinical data AHFS/Drugs.com …   Wikipedia

  • Oxymetholone — Systematic (IUPAC) name 17β hydroxy 2 hydroxymethylidene 17α methyl 3 androstanone Clinical data AHFS/Drugs.com …   Wikipedia

  • Methandrostenolone — Systematic (IUPAC) name (8S,9S,10S,13S,14S,17S) 17 hydroxy 10, 13,17 trimethyl 7,8,9,11,12,14,15,16 octahydro 6H cyclopenta[a]phenanthren 3 one …   Wikipedia

  • Major League Baseball drug policy — Major League Baseball s drug policy the Joint Drug Prevention and Treatment Program was established by agreement between the MLB Players Association and the Office of the Commissioner of Baseball in order to deter and end the use by baseball… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”